SEI Investments
VIVO

SEI Investments’s Meridian Bioscience Inc VIVO Stock Holding History

SEI Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,584
Closed -$474K – 2758
2022
Q2 		$474K Buy
+15,584
New +$421K ﹤0.01% 2121
2021
Q3 		– Sell
-10,145
Closed -$225K – 2664
2021
Q2 		$225K Sell
10,145
-3,006
-23% -$63.8K ﹤0.01% 2419
2021
Q1 		$322K Sell
13,151
-27,705
-68% -$659K ﹤0.01% 2222
2020
Q4 		$763K Sell
40,856
-534
-1% -$9.97K ﹤0.01% 1804
2020
Q3 		$702K Buy
41,390
+6,115
+17% +$119K ﹤0.01% 1766
2020
Q2 		$822K Buy
35,275
+7,665
+28% +$111K ﹤0.01% 1634
2020
Q1 		$232K Buy
+27,610
New +$232K ﹤0.01% 2060
2019
Q4 		– Sell
-21,407
Closed -$203K – 2465
2019
Q3 		$203K Buy
21,407
+8,647
+68% +$91.1K ﹤0.01% 2247
2019
Q2 		$152K Sell
12,760
-1,090
-8% -$13.1K ﹤0.01% 2287
2019
Q1 		$244K Buy
13,850
+2,619
+23% +$43.6K ﹤0.01% 2209
2018
Q4 		$195K Buy
+11,231
New +$192K ﹤0.01% 2040
2018
Q3 		– Sell
-107
Closed -$2K – 3595
2018
Q2 		$2K Sell
107
-86
-45% -$1.28K ﹤0.01% 3397
2018
Q1 		$2K Buy
193
+33
+21% +$488 ﹤0.01% 3278
2017
Q4 		$2K Sell
160
-6
-4% -$88 ﹤0.01% 3151
2017
Q3 		$2K Sell
166
-1,214
-88% -$17.3K ﹤0.01% 3020
2017
Q2 		$21K Hold
1,380
– – ﹤0.01% 2447
2017
Q1 		$19K Buy
1,380
+731
+113% +$10.2K ﹤0.01% 2343
2016
Q4 		$11K Buy
649
+70
+12% +$1.23K ﹤0.01% 2461
2016
Q3 		$11K Sell
579
-675
-54% -$13.2K ﹤0.01% 2390
2016
Q2 		$25K Sell
1,254
-2,066
-62% -$40.5K ﹤0.01% 2110
2016
Q1 		$68K Buy
+3,320
New +$65.4K ﹤0.01% 1763
2015
Q4 		– Sell
-19,854
Closed -$340K – 2734
2015
Q3 		$340K Buy
+19,854
New +$363K ﹤0.01% 1433

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's VIVO Position: Q3 2022 in Review

SEI Investments sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 15,584 shares — an estimated $474K sold.

SEI Investments first reported a position in VIVO in Q3 2015 and held it in 22 quarters. The position peaked at $822K in Q2 2020. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • SEI Investments reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • SEI Investments sold 15,584 Meridian Bioscience Inc shares in Q3 2022, an estimated $474K.
  • SEI Investments first reported a position in Meridian Bioscience Inc in Q3 2015 and held it in 22 quarters.
  • SEI Investments's Meridian Bioscience Inc position peaked at $822K in Q2 2020.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on SEI Investments's 13F filing for Q3 2022, filed 14 Nov 2022.